Centogene N.V. Common Shares

The European clinical biomarkers market is expected to grow significantly, driven by advancements in biotechnology, personalized treatment, and the rising prevalence of chronic diseases. Key players in the market include ALCEN, bioMerieux, Centogene, Eurofins Scientific, F. Hoffmann-La Roche, and Qiagen.

Related tickers: BMXXY, CNTG, RHHBY, QGEN.

TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, are pleased to announce the signing of a Memorandum of Understanding (MOU) to advance drug development for lysosomal diseases (LDs) and improve the quality of life for those impacted by these conditions.

Related tickers: CNTG.